• TCR2 Therapeutics Inc, a Cambridge, Mass. -
based immuno - oncology company, raised $ 125 million in Series B funding.
Not exact matches
ARMO BioSciences is a four - year - old, Redwood City -
based late - stage
immuno - oncology company.
The researchers are organized in different expert focus groups,
based on their expertise in different cancer types and research areas in
immuno - oncology.
Under the terms of the new agreement, AstraZeneca and Moderna, a pioneer of mRNA Therapeutics ™, have agreed to collaborate on two specific
immuno - oncology programs,
based on promising pre-clinical data, including pharmacology in tumor models.
These subsequent targeted approaches, whether they use other MS techniques or are
immuno -
based, are designed to validate the use of the biomarker protein (s) to distinguish one disease from another.
«Our internationally standardized, NGS -
based LymphoTrack clonality assays with bioinformatics software provide a comprehensive solution in support of laboratories and pharmaceutical companies developing new drugs and
immuno - therapies.
Co-engrafting mice with human tumors that retain the same characteristics and human immune cells, is a new platform to study the relationship between the human immune system and tumors and develop
immuno - oncology -
based cancer therapies.